Adavosertib

Overview

Adavosertib (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC 50 of 5.2 nM.

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Wee1

Product Information

• Catalog No.: HY-10993
• CAS No.: 955365-80-7
• Molecular Formula: C27H32N8O2
• Molecular Weight: 500.60
• Purity: 99.96%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 2.08 mg/mL (4.16 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source